Literature DB >> 30032052

The Mental Health Parity and Addiction Equity Act (MHPAEA) evaluation study: Did parity differentially affect substance use disorder and mental health benefits offered by behavioral healthcare carve-out and carve-in plans?

Sarah A Friedman1, Francisca Azocar2, Haiyong Xu3, Susan L Ettner4.   

Abstract

BACKGROUND: To assess whether implementation of the Mental Health Parity and Addiction Equity Act (MHPAEA) was associated with: 1. Reduced differences in financial requirements (i.e., copayments and coinsurance) for substance use disorder (SUD) versus specialty mental health (MH) care and 2. Reductions in the level of cost-sharing for SUD-specific services.
METHODS: MH and SUD copayments and coinsurance, 2008-2013, were obtained from benefits databases for carve-in and carve-out plans from Optum®. Linear regression was used to estimate the association of MHPAEA with differences between MH and SUD care financial requirements among carve-in and carve-out plans. A two-part regression model investigated whether MHPAEA was associated with changes in the use or level of financial requirements for SUD-specific services among carve-out plans.
RESULTS: MHPAEA was not associated with significant changes in the difference between SUD and MH copayments or coinsurance levels among either carve-in or carve-out plans. MHPAEA was associated with decreases in the levels of inpatient (in-network: -$51.17; out-of-network: -$34.39) and outpatient (in-network: -$10.26) detox copayments, but increases in the levels of in-network outpatient detox coinsurance (6 percentage points) among all carve-out plans.
CONCLUSION: Even if SUD benefits had been historically less generous than MH benefits, SUD financial requirements were already at parity with MH financial requirements by the time MHPAEA was passed, among Optum® plans. MHPAEA's SUD parity mandate reduced cost-sharing for detox services via copayments, but, for outpatient detox, the law simultaneously increased cost-sharing via coinsurance.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Commercial insurance; Parity; Substance use disorder

Mesh:

Year:  2018        PMID: 30032052      PMCID: PMC6197987          DOI: 10.1016/j.drugalcdep.2018.06.008

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  10 in total

1.  Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures.

Authors:  Melinda Beeuwkes Buntin; Alan M Zaslavsky
Journal:  J Health Econ       Date:  2004-05       Impact factor: 3.883

2.  A political history of federal mental health and addiction insurance parity.

Authors:  Colleen L Barry; Haiden A Huskamp; Howard H Goldman
Journal:  Milbank Q       Date:  2010-09       Impact factor: 4.911

3.  The economic costs of substance abuse treatment: updated estimates and cost bands for program assessment and reimbursement.

Authors:  Michael T French; Ioana Popovici; Lauren Tapsell
Journal:  J Subst Abuse Treat       Date:  2008-02-21

4.  The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Specialty Behavioral Health Care Utilization and Spending Among Carve-In Enrollees.

Authors:  Jessica M Harwood; Francisca Azocar; Amber Thalmayer; Haiyong Xu; Michael K Ong; Chi-Hong Tseng; Kenneth B Wells; Sarah Friedman; Susan L Ettner
Journal:  Med Care       Date:  2017-02       Impact factor: 2.983

5.  The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral health utilization and expenditures among "carve-out" enrollees.

Authors:  Susan L Ettner; Jessica M Harwood; Amber Thalmayer; Michael K Ong; Haiyong Xu; Michael J Bresolin; Kenneth B Wells; Chi-Hong Tseng; Francisca Azocar
Journal:  J Health Econ       Date:  2016-09-30       Impact factor: 3.883

6.  The Mental Health Parity and Addiction Equity Act evaluation study: Impact on specialty behavioral healthcare utilization and spending among enrollees with substance use disorders.

Authors:  Sarah Friedman; Haiyong Xu; Jessica M Harwood; Francisca Azocar; Brian Hurley; Susan L Ettner
Journal:  J Subst Abuse Treat       Date:  2017-06-26

7.  The Mental Health Parity and Addiction Equity Act (MHPAEA) Evaluation Study: Impact on Quantitative Treatment Limits.

Authors:  Amber Gayle Thalmayer; Sarah A Friedman; Francisca Azocar; Jessica M Harwood; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2016-12-15       Impact factor: 3.084

8.  The Mental Health Parity and Addiction Equity Act Evaluation Study: Impact on Mental Health Financial Requirements among Commercial "Carve-In" Plans.

Authors:  Sarah A Friedman; Amber G Thalmayer; Francisca Azocar; Haiyong Xu; Jessica M Harwood; Michael K Ong; Laura Lambert Johnson; Susan L Ettner
Journal:  Health Serv Res       Date:  2016-12-12       Impact factor: 3.402

9.  Behavioral health parity and the Affordable Care Act.

Authors:  Richard G Frank; Kirsten Beronio; Sherry A Glied
Journal:  J Soc Work Disabil Rehabil       Date:  2014

10.  Health Plans' Early Response to Federal Parity Legislation for Mental Health and Addiction Services.

Authors:  Constance M Horgan; Dominic Hodgkin; Maureen T Stewart; Amity Quinn; Elizabeth L Merrick; Sharon Reif; Deborah W Garnick; Timothy B Creedon
Journal:  Psychiatr Serv       Date:  2015-09-15       Impact factor: 3.084

  10 in total
  3 in total

1.  U.S. alcohol treatment admissions after the Mental Health Parity and Addiction Equity Act: Do state parity laws and race/ethnicity make a difference?

Authors:  Nina Mulia; Camillia K Lui; Yu Ye; Meenakshi S Subbaraman; William C Kerr; Thomas K Greenfield
Journal:  J Subst Abuse Treat       Date:  2019-08-20

2.  Quantifying Balance Billing for Out-of-Network Behavioral Health Care in Employer-Sponsored Insurance.

Authors:  Sarah A Friedman; Haiyong Xu; Francisca Azocar; Susan L Ettner
Journal:  Psychiatr Serv       Date:  2022-03-23       Impact factor: 4.157

3.  Insurance expansions and adolescent use of substance use disorder treatment.

Authors:  Sarah Hamersma; Johanna Catherine Maclean
Journal:  Health Serv Res       Date:  2020-11-18       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.